Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States; Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, United States
Louise H Moncla
Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, United States; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Rachel Eguia
Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, United States; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, United States
Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, United States; Computational Biology Program, Fred Hutchinson Cancer Research Center, Seattle, United States; Howard Hughes Medical Institute, Seattle, United States
Viruses like influenza are infamous for their ability to adapt to new hosts. Retrospective studies of natural zoonoses and passaging in the lab have identified a modest number of host-adaptive mutations. However, it is unclear if these mutations represent all ways that influenza can adapt to a new host. Here we take a prospective approach to this question by completely mapping amino-acid mutations to the avian influenza virus polymerase protein PB2 that enhance growth in human cells. We identify numerous previously uncharacterized human-adaptive mutations. These mutations cluster on PB2’s surface, highlighting potential interfaces with host factors. Some previously uncharacterized adaptive mutations occur in avian-to-human transmission of H7N9 influenza, showing their importance for natural virus evolution. But other adaptive mutations do not occur in nature because they are inaccessible via single-nucleotide mutations. Overall, our work shows how selection at key molecular surfaces combines with evolutionary accessibility to shape viral host adaptation.